細胞外マトリックスパッチの世界市場（2022年～2029年）

世界の細胞外マトリックスパッチ市場は、2022年から2029年までの予測期間中に7.5%のCAGRで成長する見通しです。

当レポートでは、世界の細胞外マトリックスパッチ市場を調査し、市場の概要、セグメント・地域別の市場規模および成長率、COVID-19の分析、市場力学、業界分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 世界の細胞外マトリックスパッチ市場：調査手法と範囲

第2章 世界の細胞外マトリックスパッチ市場：市場の定義と概要

第3章 世界の細胞外マトリックスパッチ市場：エグゼクティブサマリー

• 市場内訳：原料別
• 市場内訳：用途別
• 市場内訳：地域別

第4章 世界の細胞外マトリックスパッチ市場：市場力学

• 市場に影響を与える要因
  • 促進要因：
  • ヘルニアおよび骨盤再建手術における細胞外マトリックスパッチの採用
• 抑制要因：
  • 移植片の合併症がほとんどない点
• 機会
• 影響分析

第5章 世界の細胞外マトリックスパッチ市場：業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• PEST分析

第6章 世界の細胞外マトリックスパッチ市場：COVID-19の分析

• 市場におけるCOVID-19の分析
  • COVID-19以前の市場シナリオ
  • 現在の市場シナリオ
  • COVID-19以後/将来のシナリオ
• COVID-19渦中の価格のダイナミクス
• 需要と供給のスペクトル
• パンデミック時の市場に関連する政府イニシアチブ
• メーカーの戦略的イニシアチブ
• 総論

第7章 世界の細胞外マトリックスパッチ市場：原料別

• イントロダクション
  • 市場規模の分析・前年比成長率の分析：原料別
  • 市場魅力指数：原料別
• ブタ
• ウシ
• その他

第8章 世界の細胞外マトリックスパッチ市場：用途別

• イントロダクション
  • 市場規模の分析・前年比成長率の分析：用途別
  • 市場魅力指数：用途別
• 心臓の修復
• 軟部組織の修復
• 血管の修復と再建
• その他

第9章 世界の細胞外マトリックスパッチ市場：地域別

• イントロダクション
  • 市場規模の分析・前年比成長率の分析：地域別
  • 市場魅力指数：地域別
• 北米
• 欧州
• 南米
• アジア太平洋地域
• 中東・アフリカ

第10章 世界の細胞外マトリックスパッチ市場：競合情勢

• 競合シナリオ
• 主な発展と戦略
• 企業シェア分析
• 製品のベンチマーク
• 注目すべき主要企業
• 破壊的技術を有する企業

第11章 企業プロファイル

• Baxter International
• Becton, Dickinson, and Company
• Terumo Corporation
• LeMaitre
• Smith+Nephew
• Aziyo Biologics
• Integra LifeSciences Corporation
• Coloplast, Medtronic
• MTF Biologics
• Koninklijke DSM N.V

第12章 世界の細胞外マトリックスパッチ市場：DataM

• 付録
• 当社・サービスについて
• お問い合わせ

Market Overview

Extracellular matrix patches market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 7.5 % during the forecast period (2022-2029).

The extracellular matrix patches are a 3D network consisting of extracellular macromolecules that are used to provide support to the surrounding cells. It promotes a regenerative or healing pathway and facilitates tissue remodeling. It is used to support tissues segregating one another and regulate intercellular communication.

Market Dynamics

The growth of the extracellular matrix patches market is due to the rise in prevalence of trauma, congenital heart disease, rise in prevalence of vascular diseases, increase in vascular surgeries and a surge in the geriatric population which require reconstruction and repair procedures.

Adoption of extracellular matrix patch in hernia and pelvic reconstruction surgeries is expected to hold the largest share in this market segment

According to the data published by Health System Tracker, 2022, it has been observed that heart disease is the number one leading cause of death in the United States. The World Heart Federation has predicted more than 23 million cardiac-related deaths per year by 2030. One of the major elements driving the expansion of extracellular matrix patches is a growing knowledge of the advantages of biological patches over synthetic ones. Increasing adoption of extracellular matrix in hernia and pelvic reconstruction surgeries promotes the growth of these products and rising technological advancements have favored the market growth. For instance, Aziyo Biologics' AltiPly patch is a ready-to-use patch that does not require rehydration and is easy to handle at room temperature. It involves patented processing that boosts growth level variables and speeds up the healing process in situations of venous leg ulcers, diabetic foot ulcers, and pressure wounds.

For example, abdominal wall hernia surgery is one of the most common procedures performed around the world. The extracellular matrix is being developed by several businesses for pelvic reconstruction and hernia surgery. For instance, Boston Scientific Corporation's Xenform Soft Tissue Repair Matrix is suggested for soft tissue regeneration, particularly in cases of pelvic organ prolapse. Moreover, the companies are focusing on developing extracellular matrix for soft tissues repair. For instance, in February 2020, Aroa Biosurgery launched Myriad a new product for soft tissue repair and reconstruction, in the United States market. Myriad can be used for a variety of plastic and reconstructive surgical operations that require the repair or reinforcement of soft tissue, including as plastic surgery, limb salvage, burns, and trauma.

Few complications of these grafts are likely to hinder the market growth

However, in the past few years, many of these products have undergone recalls, which in turn, hinder its adoption levels. In addition, the use of extracellular matrix grafts involves various complications such as allergies, chronic inflammation, pain, swelling, and redness, which may adversely impact its growth.

COVID-19 Impact Analysis

COVID-19 has impacted the healthcare industry. The restrictions imposed by the government across the world have impacted the treatment and surgeries of the patients. The recognition of the need to limit operative capacity to only emergent and/or urgent procedures have resulted in delayed elective cardiac and vascular procedure and surgeries. The guidelines were set forth by national surgical and specialty societies. According to the study published in the British Journal of Surgery, in May 2020, "Elective surgery cancellations due to the COVID-19 pandemic: global predictive modeling to inform surgical recovery plans" based on a 12-week period of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide were cancelled or postponed in 2020. More than 580,000 planned surgeries in India were cancelled or delayed as a result of the COVID-19 pandemic.

Segment Analysis

The cardiac repair segment is expected to hold the largest share in this market segment

The main factor driving the market's growth is the increasing number of cardiovascular diseases. According to the National Center of Biotechnology Information, 2020, around 64.3 million people suffer from heart failure worldwide. In addition, the prevalence rate of heart failure in the adult population is about 0.8% to 4.0%. According to the data published by Philippine Statistics Authority (PSA), 2020, it has been observed that ischaemic heart diseases were the leading cause of death from January to October 2021, with 110,332 cases or 18.3% of the total deaths in the country. Moreover, the number of children with congenital heart diseases has been increasing over the past year and thus leading to the adoption of these cardiovascular repair patches for diagnosing and driving the overall market.

The decentralized extracellular matrix patches are widely used in cardiac tissue repair. For instance, according to the National Center for Biotechnology Information, 2020, the rich array of proteins, glycosaminoglycans, proteoglycans, and many other matrix components found in natural tissue are most efficiently captured by decellularized extracellular matrix (dECM), offering perfect cues for regeneration and repair of injured myocardium. This makes dECM a promising biomaterial for repairing cardiovascular tissue.

Geographical Analysis

North America region holds the largest market share of global extracellular matrix patches market

North America is expected to witness a significant share of market growth in the forecast period. The factors propelling the growth of the market are the increasing incidence of cardiovascular diseases and defects, sports injuries, trauma cases, growing research and development expenditure, and increasing incidences of hernia disorders. According to the American Association for the Surgery of Trauma, 2021, trauma is the leading cause of death for individuals up to the age of 45 years. As per the same source, the annual toll of trauma in the United States is USD 4.2 trillion.

In addition, the rising geriatric population is also likely to boost the market growth as they are more prone to cardiovascular diseases. According to the Administration for Community Living report 2020, the number of Americans aged 65 and above was 16.9% of the total population in 2020, and it is estimated to about double to 94.7 million by 2060, and the 65-and-older age group's share of the total population will rise from 16% to 21.6% in the United States. According to the Center for Disease Control and Prevention, Coronary heart disease is the most common type of heart disease, killing 360,900 people in 2019 in the United States.

Moreover, the United States spends a significant percentage of its GDP on healthcare, each year. According to Organization for Economic Cooperation and Development, 2021, the United States has the greatest healthcare spending, sitting at USD 10,224 per capita.

Competitive Landscape

The global extracellular matrix patches market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Baxter International, Becton, Dickinson, and Company, Terumo Corporation, LeMaitre, Smith+Nephew, Aziyo Biologics, Integra LifeSciences Corporation, Coloplast, Medtronic, MTF Biologics, Koninklijke DSM N.V. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the hydrocephalus shunts globally. For instance, In November 2021, Sanara MedTech Inc. launches two new innovative extracellular matrix products, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix, from Cook Biotech Inc. This will assist the company to build upon its comprehensive portfolio of surgical and wound care products without replacing any of its existing CellerateRX Surgical products.

Key Companies to Watch

Baxter International

Overview: Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions.

Product Portfolio: It includes products like PERI-GUARD, VASCU-GUARD and DURA-GUARD patches.

Recent Development:

In January 2021, JellaGel Launched its 3-dimensional hydrogel, JellaGel Hydrogel. It allows cells to grow and interact with all of their surroundings which makes a huge difference.

In September 2021. the company Terumo Corporation announced the launch of a global surgical graft study known as PANTHER, which is a perspective and retrospective study of a comprehensive range of knitted and woven surgical grafts and cardiovascular patches.

In June 2021, Axio Biosolutions announced the US Food and Drug Administration's clearance of its product Axiostat Patch, which helps in the control of moderate to severe bleeding in vascular procedures.

Why Purchase the Report?

• Visualize the composition of the extracellular matrix patches market segmentation by raw material, application, and region highlighting the key commercial assets and players.
• Identify commercial opportunities in extracellular matrix patches market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of extracellular matrix patches market - level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players.

The global extracellular matrix patches market report would provide an access to an approx. 50 market data table, 45 figures and 180 pages.

Target Audience

• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers

Table of Contents

1. Global Extracellular Matrix Patches Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Extracellular Matrix Patches Market - Market Definition and Overview

3. Global Extracellular Matrix Patches Market - Executive Summary

• 3.1. Market Snippet by Raw Material
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by Region

4. Global Extracellular Matrix Patches Market - Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers:
  • 4.1.2. Adoption of extracellular matrix patch in hernia and pelvic reconstruction surgeries
• 4.2. Restraints:
  • 4.2.1. Few complications of these grafts
• 4.3. Opportunity
• 4.4. Impact Analysis

5. Global Extracellular Matrix Patches Market - Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. PEST Analysis

6. Global Extracellular Matrix Patches Market - COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Global Extracellular Matrix Patches Market - By Raw Material

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Raw Material
  • 7.1.2. Market Attractiveness Index, By Raw Material
• 7.2. Porcine*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Bovine
• 7.4. Others

8. Global Extracellular Matrix Patches Market - By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Cardiac Repair*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Soft Tissue Repair
• 8.4. Vascular Repair & Reconstruction
• 8.5. Others

9. Global Extracellular Matrix Patches Market - By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Raw Material
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Raw Material
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Raw Material
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Raw Material
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Raw Material
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Global Extracellular Matrix Patches Market - Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Key Developments and Strategies
• 10.3. Company Share Analysis
• 10.4. Product Benchmarking
• 10.5. Key Companies to Watch
• 10.6. Company with disruptive technology

11. Global Extracellular Matrix Patches Market- Company Profiles

• 11.1. Baxter International*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. Becton, Dickinson, and Company
• 11.3. Terumo Corporation
• 11.4. LeMaitre
• 11.5. Smith+Nephew
• 11.6. Aziyo Biologics
• 11.7. Integra LifeSciences Corporation
• 11.8. Coloplast, Medtronic
• 11.9. MTF Biologics
• 11.10. Koninklijke DSM N.V

LIST NOT EXHAUSTIVE

12. Global Extracellular Matrix Patches Market - DataM

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us